Condition

Philadelphia Positive (2)

Acute Lymphoblastic Leukemia (1)

BCR-ABL Positive (1)

Chronic Myeloid Leukemia (1)

Overall Status

Completed (1)

Terminated (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

Gruppo Italiano Malattie EMatologiche dell'Adulto (1)

Incyte Corporation (1)

Collaborator

Intervention

ponatinib (2)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (1)

Observational (1)

philadelphia positive

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

CML Patients in the National Compassionate Program

Terminated

Chronic Myeloid Leukemia
Philadelphia Positive

Ponatinib

Bari, Italy
+9 more

Oct 24, 2022

Philadelphia Positive, BCR-ABL Positive, Acute Lymphoblastic Leukemia Trial in Italy (Ponatinib)

Completed

Philadelphia Positive
+2 more

Ponatinib

Alessandria, Italy
+41 more

Nov 18, 2021